{
  "metadata": {
    "generated": "2026-02-05T01:52:27.432464",
    "description": "Novel biologic drug repurposing predictions",
    "total_predictions": 124,
    "by_tier": {
      "GOLDEN": 2,
      "HIGH": 26,
      "MEDIUM": 96
    },
    "key_drugs": [
      "Pembrolizumab (checkpoint inhibitor)",
      "Rituximab (anti-CD20)",
      "Adalimumab (TNF inhibitor)"
    ],
    "validation_notes": [
      "Pembrolizumab -> cholangiocarcinoma: FDA-APPROVED (should be GT gap)",
      "Adalimumab -> autoimmune hepatitis: FALSE POSITIVE (TNF can CAUSE AIH)",
      "Rituximab -> glaucoma: Indirect evidence (reduces steroid-induced glaucoma)"
    ]
  },
  "predictions": [
    {
      "disease_name": "glaucoma",
      "disease_id": "drkg:Disease::MESH:D005901",
      "disease_category": "ophthalmic",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 0.6153537631034851,
      "norm_score": 0.38741645216941833,
      "confidence_tier": "GOLDEN",
      "train_frequency": 10,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "systemic myasthenia gravis",
      "disease_id": "drkg:Disease::MESH:D009157",
      "disease_category": "autoimmune",
      "disease_tier": 1,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 1.3265396356582642,
      "norm_score": 0.22437416017055511,
      "confidence_tier": "GOLDEN",
      "train_frequency": 11,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "osteosarcoma",
      "disease_id": "drkg:Disease::MESH:D012516",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 1,
      "knn_score": 2.879044532775879,
      "norm_score": 1.0,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "ewing sarcoma",
      "disease_id": "drkg:Disease::MESH:D012512",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 1,
      "knn_score": 2.1292920112609863,
      "norm_score": 1.0,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "cholangiocarcinoma",
      "disease_id": "drkg:Disease::MESH:D018281",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 1,
      "knn_score": 1.9713969230651855,
      "norm_score": 1.0,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "acute promyelocytic leukemia",
      "disease_id": "drkg:Disease::MESH:D015473",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 2,
      "knn_score": 1.2055524587631226,
      "norm_score": 0.990480899810791,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "retinoblastoma",
      "disease_id": "drkg:Disease::MESH:D012175",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 8,
      "knn_score": 1.3772222995758057,
      "norm_score": 0.953000009059906,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "osteosarcoma",
      "disease_id": "drkg:Disease::MESH:D012516",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Nivolumab",
      "drug_id": "drkg:Compound::DB09035",
      "drug_type": "biologic",
      "rank": 2,
      "knn_score": 2.284445285797119,
      "norm_score": 0.7934734225273132,
      "confidence_tier": "HIGH",
      "train_frequency": 12,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "leiomyosarcoma",
      "disease_id": "drkg:Disease::MESH:D007890",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 2,
      "knn_score": 2.377150297164917,
      "norm_score": 0.7832331657409668,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "soft tissue sarcoma",
      "disease_id": "drkg:Disease::MESH:D012509",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 2,
      "knn_score": 2.1419718265533447,
      "norm_score": 0.7629883289337158,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "medulloblastoma",
      "disease_id": "drkg:Disease::MESH:D008527",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 3,
      "knn_score": 1.541161298751831,
      "norm_score": 0.7192627191543579,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "mast cell leukemia",
      "disease_id": "drkg:Disease::MESH:D007945",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 6,
      "knn_score": 1.5154457092285156,
      "norm_score": 0.6522738933563232,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "mantle cell lymphoma",
      "disease_id": "drkg:Disease::MESH:D020522",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 6,
      "knn_score": 1.5545923709869385,
      "norm_score": 0.643268883228302,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "atherosclerosis",
      "disease_id": "drkg:Disease::MESH:D050197",
      "disease_category": "cardiovascular",
      "disease_tier": 2,
      "drug_name": "Evolocumab",
      "drug_id": "drkg:Compound::DB09303",
      "drug_type": "biologic",
      "rank": 5,
      "knn_score": 1.4324171543121338,
      "norm_score": 0.6122381687164307,
      "confidence_tier": "HIGH",
      "train_frequency": 5,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": true,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "relapsed or refractory acute myeloid leukemia",
      "disease_id": "drkg:Disease::MESH:D007951",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 9,
      "knn_score": 1.3950951099395752,
      "norm_score": 0.5799114108085632,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "acute lymphoblastic leukemia",
      "disease_id": "drkg:Disease::MESH:D054198",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 10,
      "knn_score": 1.1992180347442627,
      "norm_score": 0.5398192405700684,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "anaplastic large cell lymphoma",
      "disease_id": "drkg:Disease::MESH:D017728",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 12,
      "knn_score": 0.7573740482330322,
      "norm_score": 0.5148835778236389,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "burkitt lymphoma",
      "disease_id": "drkg:Disease::MESH:D002051",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 10,
      "knn_score": 0.7889391779899597,
      "norm_score": 0.513084352016449,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "persistent recurrent or metastatic carcinoma of the cervix",
      "disease_id": "drkg:Disease::MESH:D009362",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 4,
      "knn_score": 1.1427090167999268,
      "norm_score": 0.5108270049095154,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "multiple myeloma",
      "disease_id": "drkg:Disease::MESH:D009101",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.0872924327850342,
      "norm_score": 0.5038782954216003,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "neuroblastoma",
      "disease_id": "drkg:Disease::MESH:D009447",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 6,
      "knn_score": 1.489195466041565,
      "norm_score": 0.4921784996986389,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "pancreatitis",
      "disease_id": "drkg:Disease::MESH:D010195",
      "disease_category": "gastrointestinal",
      "disease_tier": 3,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 5,
      "knn_score": 0.4485369920730591,
      "norm_score": 0.44853687286376953,
      "confidence_tier": "HIGH",
      "train_frequency": 11,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "liposarcoma",
      "disease_id": "drkg:Disease::MESH:D008080",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 9,
      "knn_score": 0.792274534702301,
      "norm_score": 0.4477066099643707,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "glioma",
      "disease_id": "drkg:Disease::MESH:D005910",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 6,
      "knn_score": 0.789876401424408,
      "norm_score": 0.4453238248825073,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "renal angiomyolipoma and tuberous sclerosis complex tsc",
      "disease_id": "drkg:Disease::MESH:D018207",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 20,
      "knn_score": 0.7440330982208252,
      "norm_score": 0.40940606594085693,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "basal cell carcinoma bcc",
      "disease_id": "drkg:Disease::MESH:D002280",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 17,
      "knn_score": 0.6905856728553772,
      "norm_score": 0.40018725395202637,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "actinic keratosis",
      "disease_id": "drkg:Disease::MESH:D055623",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 20,
      "knn_score": 0.643458366394043,
      "norm_score": 0.37287744879722595,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "dermatofibrosarcoma protuberans",
      "disease_id": "drkg:Disease::MESH:D018223",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 9,
      "knn_score": 0.7298701405525208,
      "norm_score": 0.3043007552623749,
      "confidence_tier": "HIGH",
      "train_frequency": 15,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "chronic pancreatitis",
      "disease_id": "drkg:Disease::MESH:D050500",
      "disease_category": "gastrointestinal",
      "disease_tier": 3,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 1,
      "knn_score": 1.2654333114624023,
      "norm_score": 1.0,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "proctitis",
      "disease_id": "drkg:Disease::MESH:D011349",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 1,
      "knn_score": 1.5837153196334839,
      "norm_score": 1.0,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "retinitis",
      "disease_id": "drkg:Disease::MESH:D012173",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 2,
      "knn_score": 1.4800115823745728,
      "norm_score": 0.9975214004516602,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "pulmonary hypertension",
      "disease_id": "drkg:Disease::MESH:D006976",
      "disease_category": "cardiovascular",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 3,
      "knn_score": 1.515737533569336,
      "norm_score": 0.9955971240997314,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "proctitis",
      "disease_id": "drkg:Disease::MESH:D011349",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 10,
      "knn_score": 1.5151162147521973,
      "norm_score": 0.9566847085952759,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "retinitis",
      "disease_id": "drkg:Disease::MESH:D012173",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 8,
      "knn_score": 1.4190881252288818,
      "norm_score": 0.9564592242240906,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "ependymoma",
      "disease_id": "drkg:Disease::MESH:D004806",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 2,
      "knn_score": 1.605889081954956,
      "norm_score": 0.9100257158279419,
      "confidence_tier": "MEDIUM",
      "train_frequency": 15,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "ischemic cerebrovascular disorder",
      "disease_id": "drkg:Disease::MESH:D002561",
      "disease_category": "cardiovascular",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 7,
      "knn_score": 1.2198737859725952,
      "norm_score": 0.8998337984085083,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "lymphoplasmacytic lymphoma",
      "disease_id": "drkg:Disease::MESH:D008258",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 4,
      "knn_score": 1.6277391910552979,
      "norm_score": 0.8902575373649597,
      "confidence_tier": "MEDIUM",
      "train_frequency": 15,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "pancreatic neuroendocrine tumors",
      "disease_id": "drkg:Disease::MESH:D018358",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 4,
      "knn_score": 1.4989697933197021,
      "norm_score": 0.8868417739868164,
      "confidence_tier": "MEDIUM",
      "train_frequency": 15,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "peripheral vascular disease",
      "disease_id": "drkg:Disease::MESH:D016491",
      "disease_category": "cardiovascular",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 4,
      "knn_score": 1.3139595985412598,
      "norm_score": 0.8180590271949768,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "edema",
      "disease_id": "drkg:Disease::MESH:D004487",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 5,
      "knn_score": 1.4438221454620361,
      "norm_score": 0.7425538301467896,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "proteinuria",
      "disease_id": "drkg:Disease::MESH:D011507",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 10,
      "knn_score": 2.6501824855804443,
      "norm_score": 0.6479057669639587,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "cholangiocarcinoma",
      "disease_id": "drkg:Disease::MESH:D018281",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Nivolumab",
      "drug_id": "drkg:Compound::DB09035",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 1.2704319953918457,
      "norm_score": 0.6444323658943176,
      "confidence_tier": "MEDIUM",
      "train_frequency": 12,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "ewing sarcoma",
      "disease_id": "drkg:Disease::MESH:D012512",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Nivolumab",
      "drug_id": "drkg:Compound::DB09035",
      "drug_type": "biologic",
      "rank": 15,
      "knn_score": 1.346858263015747,
      "norm_score": 0.6325380802154541,
      "confidence_tier": "MEDIUM",
      "train_frequency": 12,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "cerebral infarction",
      "disease_id": "drkg:Disease::MESH:D002544",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 17,
      "knn_score": 1.005149245262146,
      "norm_score": 0.6225394606590271,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "transthyretin familial amyloid polyneuropathy",
      "disease_id": "drkg:Disease::MESH:D011115",
      "disease_category": "neurological",
      "disease_tier": 3,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 3,
      "knn_score": 2.0589494705200195,
      "norm_score": 0.6073924899101257,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "disseminated intravascular coagulation dic",
      "disease_id": "drkg:Disease::MESH:D004211",
      "disease_category": "cardiovascular",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 6,
      "knn_score": 2.3858447074890137,
      "norm_score": 0.5899733304977417,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "atherosclerosis",
      "disease_id": "drkg:Disease::MESH:D050197",
      "disease_category": "cardiovascular",
      "disease_tier": 2,
      "drug_name": "Alirocumab",
      "drug_id": "drkg:Compound::DB09302",
      "drug_type": "biologic",
      "rank": 8,
      "knn_score": 1.3093488216400146,
      "norm_score": 0.5596367716789246,
      "confidence_tier": "MEDIUM",
      "train_frequency": 6,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "neovascular glaucoma",
      "disease_id": "drkg:Disease::MESH:D015355",
      "disease_category": "cardiovascular",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 6,
      "knn_score": 1.5905394554138184,
      "norm_score": 0.526106595993042,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "acute erythroid leukemia",
      "disease_id": "drkg:Disease::MESH:D004915",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 11,
      "knn_score": 0.7081363201141357,
      "norm_score": 0.5194030404090881,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "lipodystrophy",
      "disease_id": "drkg:Disease::MESH:D008060",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 15,
      "knn_score": 0.6894378662109375,
      "norm_score": 0.5163451433181763,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "spina bifida",
      "disease_id": "drkg:Disease::MESH:D016135",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 5,
      "knn_score": 0.7345466613769531,
      "norm_score": 0.5123640298843384,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "melanoma",
      "disease_id": "drkg:Disease::MESH:D008545",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Bevacizumab",
      "drug_id": "drkg:Compound::DB00112",
      "drug_type": "biologic",
      "rank": 5,
      "knn_score": 1.0422158241271973,
      "norm_score": 0.5122319459915161,
      "confidence_tier": "MEDIUM",
      "train_frequency": 8,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "leiomyosarcoma",
      "disease_id": "drkg:Disease::MESH:D007890",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Nivolumab",
      "drug_id": "drkg:Compound::DB09035",
      "drug_type": "biologic",
      "rank": 16,
      "knn_score": 1.5137786865234375,
      "norm_score": 0.4987659752368927,
      "confidence_tier": "MEDIUM",
      "train_frequency": 12,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "chronic granulomatous disease",
      "disease_id": "drkg:Disease::MESH:D006105",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 12,
      "knn_score": 2.506208896636963,
      "norm_score": 0.49777287244796753,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "neovascular glaucoma",
      "disease_id": "drkg:Disease::MESH:D015355",
      "disease_category": "cardiovascular",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.5014431476593018,
      "norm_score": 0.49663597345352173,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "soft tissue sarcoma",
      "disease_id": "drkg:Disease::MESH:D012509",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Nivolumab",
      "drug_id": "drkg:Compound::DB09035",
      "drug_type": "biologic",
      "rank": 12,
      "knn_score": 1.394164800643921,
      "norm_score": 0.49661320447921753,
      "confidence_tier": "MEDIUM",
      "train_frequency": 12,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "bronchogenic carcinoma",
      "disease_id": "drkg:Disease::MESH:D002283",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 17,
      "knn_score": 0.7274777293205261,
      "norm_score": 0.49548253417015076,
      "confidence_tier": "MEDIUM",
      "train_frequency": 15,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "eosinophilic esophagitis",
      "disease_id": "drkg:Disease::MESH:D057765",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 12,
      "knn_score": 2.480470657348633,
      "norm_score": 0.4893084168434143,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "paroxysmal nocturnal hemoglobinuria pnh",
      "disease_id": "drkg:Disease::MESH:D006457",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 1.4105106592178345,
      "norm_score": 0.4879550039768219,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "superficial papillary carcinoma of the urinary bladder",
      "disease_id": "drkg:Disease::MESH:D002291",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 11,
      "knn_score": 0.7799960374832153,
      "norm_score": 0.4821907877922058,
      "confidence_tier": "MEDIUM",
      "train_frequency": 15,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "chronic diarrhea associated with inflammatory bowel disease",
      "disease_id": "drkg:Disease::MESH:D015212",
      "disease_category": "gastrointestinal",
      "disease_tier": 3,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 1.2518939971923828,
      "norm_score": 0.4533033072948456,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "systemic myasthenia gravis",
      "disease_id": "drkg:Disease::MESH:D009157",
      "disease_category": "autoimmune",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 11,
      "knn_score": 2.6793394088745117,
      "norm_score": 0.45319002866744995,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "ependymoma",
      "disease_id": "drkg:Disease::MESH:D004806",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Nivolumab",
      "drug_id": "drkg:Compound::DB09035",
      "drug_type": "biologic",
      "rank": 15,
      "knn_score": 0.7822778224945068,
      "norm_score": 0.44330140948295593,
      "confidence_tier": "MEDIUM",
      "train_frequency": 12,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "proliferative diabetic retinopathy pdr",
      "disease_id": "drkg:Disease::MESH:D003930",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 11,
      "knn_score": 0.7639508247375488,
      "norm_score": 0.44200199842453003,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "cystinuria",
      "disease_id": "drkg:Disease::MESH:D003555",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 0.6182303428649902,
      "norm_score": 0.43728503584861755,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "neuromyelitis optica spectrum disorder",
      "disease_id": "drkg:Disease::MESH:D009471",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 12,
      "knn_score": 2.3123624324798584,
      "norm_score": 0.4242553114891052,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "liposarcoma",
      "disease_id": "drkg:Disease::MESH:D008080",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 19,
      "knn_score": 0.7445739507675171,
      "norm_score": 0.4207514822483063,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "pityriasis rubra pilaris",
      "disease_id": "drkg:Disease::MESH:D010916",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 12,
      "knn_score": 1.5324912071228027,
      "norm_score": 0.41405728459358215,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "idiopathic pulmonary fibrosis",
      "disease_id": "drkg:Disease::MESH:D054990",
      "disease_category": "respiratory",
      "disease_tier": 3,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 10,
      "knn_score": 0.7151170969009399,
      "norm_score": 0.41330990195274353,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "myocardial ischemia",
      "disease_id": "drkg:Disease::MESH:D017202",
      "disease_category": "cardiovascular",
      "disease_tier": 2,
      "drug_name": "Evolocumab",
      "drug_id": "drkg:Compound::DB09303",
      "drug_type": "biologic",
      "rank": 16,
      "knn_score": 0.6811926364898682,
      "norm_score": 0.40156567096710205,
      "confidence_tier": "MEDIUM",
      "train_frequency": 5,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "neuropathy",
      "disease_id": "drkg:Disease::MESH:D010523",
      "disease_category": "neurological",
      "disease_tier": 3,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 7,
      "knn_score": 0.6127766966819763,
      "norm_score": 0.4004642069339752,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "hypereosinophilic syndrome",
      "disease_id": "drkg:Disease::MESH:D017681",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 11,
      "knn_score": 1.5278890132904053,
      "norm_score": 0.39843595027923584,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "transthyretin familial amyloid polyneuropathy",
      "disease_id": "drkg:Disease::MESH:D011115",
      "disease_category": "neurological",
      "disease_tier": 3,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 15,
      "knn_score": 1.3409901857376099,
      "norm_score": 0.39559364318847656,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "hereditary chronic cholestasis",
      "disease_id": "drkg:Disease::MESH:D002779",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 10,
      "knn_score": 1.1301922798156738,
      "norm_score": 0.39335763454437256,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "larynx cancer",
      "disease_id": "drkg:Disease::MESH:D007822",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 16,
      "knn_score": 0.6268032193183899,
      "norm_score": 0.3854885399341583,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "primary biliary cholangitis",
      "disease_id": "drkg:Disease::MESH:D008105",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 17,
      "knn_score": 0.7645187973976135,
      "norm_score": 0.3790731728076935,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "celiac disease",
      "disease_id": "drkg:Disease::MESH:D002446",
      "disease_category": "gastrointestinal",
      "disease_tier": 3,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.4233007431030273,
      "norm_score": 0.37237548828125,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "pleural mesothelioma",
      "disease_id": "drkg:Disease::MESH:D008654",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Bevacizumab",
      "drug_id": "drkg:Compound::DB00112",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 0.7421020269393921,
      "norm_score": 0.36556732654571533,
      "confidence_tier": "MEDIUM",
      "train_frequency": 8,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "neuropathy",
      "disease_id": "drkg:Disease::MESH:D010523",
      "disease_category": "neurological",
      "disease_tier": 3,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 16,
      "knn_score": 0.5570492148399353,
      "norm_score": 0.3640449643135071,
      "confidence_tier": "MEDIUM",
      "train_frequency": 15,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "systemic sclerosis associated interstitial lung disease",
      "disease_id": "drkg:Disease::MESH:D017563",
      "disease_category": "respiratory",
      "disease_tier": 3,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 0.7493038177490234,
      "norm_score": 0.35631677508354187,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "medulloblastoma",
      "disease_id": "drkg:Disease::MESH:D008527",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 0.7481950521469116,
      "norm_score": 0.34918397665023804,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "eczema",
      "disease_id": "drkg:Disease::MESH:D004485",
      "disease_category": "dermatological",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 11,
      "knn_score": 2.869886636734009,
      "norm_score": 0.34739717841148376,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "acquired hemophilia a",
      "disease_id": "drkg:Disease::MESH:D006467",
      "disease_category": "hematological",
      "disease_tier": 3,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 20,
      "knn_score": 0.7102835178375244,
      "norm_score": 0.34337371587753296,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "neuroblastoma",
      "disease_id": "drkg:Disease::MESH:D009447",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 16,
      "knn_score": 1.0221240520477295,
      "norm_score": 0.33781158924102783,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "langerhans cell histiocytosis",
      "disease_id": "drkg:Disease::MESH:D006646",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 0.7407528758049011,
      "norm_score": 0.33571991324424744,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "choriocarcinoma",
      "disease_id": "drkg:Disease::MESH:D002822",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Pembrolizumab",
      "drug_id": "drkg:Compound::DB09037",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 0.6443049311637878,
      "norm_score": 0.3304658830165863,
      "confidence_tier": "MEDIUM",
      "train_frequency": 15,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "proteinuria",
      "disease_id": "drkg:Disease::MESH:D011507",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 16,
      "knn_score": 1.3466672897338867,
      "norm_score": 0.3292277157306671,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "eosinophilic granulomatosis with polyangiitis",
      "disease_id": "drkg:Disease::MESH:D014890",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 2.4446046352386475,
      "norm_score": 0.30198854207992554,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "aplastic anemia",
      "disease_id": "drkg:Disease::MESH:D000741",
      "disease_category": "hematological",
      "disease_tier": 3,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 12,
      "knn_score": 2.1768031120300293,
      "norm_score": 0.29735487699508667,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "autoimmune hepatitis",
      "disease_id": "drkg:Disease::MESH:D019693",
      "disease_category": "autoimmune",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 15,
      "knn_score": 1.529789924621582,
      "norm_score": 0.2872922718524933,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "urothelial carcinoma",
      "disease_id": "drkg:Disease::MESH:D002295",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 20,
      "knn_score": 0.669177770614624,
      "norm_score": 0.2864283323287964,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "posterior uveitis",
      "disease_id": "drkg:Disease::MESH:D015866",
      "disease_category": "ophthalmic",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 12,
      "knn_score": 1.5806007385253906,
      "norm_score": 0.27595892548561096,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "uveitis",
      "disease_id": "drkg:Disease::MESH:D014605",
      "disease_category": "ophthalmic",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 2.3788487911224365,
      "norm_score": 0.26851552724838257,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "polymyositis",
      "disease_id": "drkg:Disease::MESH:D017285",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 2.474911689758301,
      "norm_score": 0.2617892622947693,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "systemic mastocytosis with associated hematological neoplasm",
      "disease_id": "drkg:Disease::MESH:D034721",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 0.6907708048820496,
      "norm_score": 0.25709161162376404,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "rectal cancer",
      "disease_id": "drkg:Disease::MESH:D012004",
      "disease_category": "cancer",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 17,
      "knn_score": 0.5993413925170898,
      "norm_score": 0.25650304555892944,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "myxedema",
      "disease_id": "drkg:Disease::MESH:D009230",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 0.7270848155021667,
      "norm_score": 0.2559046447277069,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "acquired thrombotic thrombocytopenic purpura",
      "disease_id": "drkg:Disease::MESH:D011697",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.43406081199646,
      "norm_score": 0.24411015212535858,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "nephrotic syndrome",
      "disease_id": "drkg:Disease::MESH:D009404",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 15,
      "knn_score": 1.284644603729248,
      "norm_score": 0.22912541031837463,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "symptomatic sarcoidosis",
      "disease_id": "drkg:Disease::MESH:D012507",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 2.382570266723633,
      "norm_score": 0.2262035459280014,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "bursitis",
      "disease_id": "drkg:Disease::MESH:D002062",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 2.480184555053711,
      "norm_score": 0.22504208981990814,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "tenosynovitis",
      "disease_id": "drkg:Disease::MESH:D013717",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 2.4891467094421387,
      "norm_score": 0.2248375415802002,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "graft versus host disease gvhd",
      "disease_id": "drkg:Disease::MESH:D006086",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 16,
      "knn_score": 1.4339957237243652,
      "norm_score": 0.21799783408641815,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "crohns disease",
      "disease_id": "drkg:Disease::MESH:D003424",
      "disease_category": "autoimmune",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 17,
      "knn_score": 1.4833080768585205,
      "norm_score": 0.20908506214618683,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "alopecia areata",
      "disease_id": "drkg:Disease::MESH:D000506",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 0.7860838174819946,
      "norm_score": 0.20825879275798798,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "interstitial pneumonia associated with polymyositisdermatomyositis",
      "disease_id": "drkg:Disease::MESH:D003882",
      "disease_category": "infectious",
      "disease_tier": 3,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 2.34298038482666,
      "norm_score": 0.20456267893314362,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "vernal keratoconjunctivitis",
      "disease_id": "drkg:Disease::MESH:D003233",
      "disease_category": "ophthalmic",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.4736392498016357,
      "norm_score": 0.20356793701648712,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "vasculitis",
      "disease_id": "drkg:Disease::MESH:D014657",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 1.5154366493225098,
      "norm_score": 0.1937810331583023,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "toxic epidermal necrolysis",
      "disease_id": "drkg:Disease::MESH:D004893",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 1.6188337802886963,
      "norm_score": 0.18192332983016968,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "polyarticularcourse juvenile idiopathic arthritis",
      "disease_id": "drkg:Disease::MESH:D001171",
      "disease_category": "autoimmune",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 1.5079691410064697,
      "norm_score": 0.1818636655807495,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "toxic epidermal necrolysis",
      "disease_id": "drkg:Disease::MESH:D004893",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.591672658920288,
      "norm_score": 0.17887099087238312,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "polymyositis",
      "disease_id": "drkg:Disease::MESH:D017285",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.6779026985168457,
      "norm_score": 0.17748387157917023,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "temporal arteritis",
      "disease_id": "drkg:Disease::MESH:D013700",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 1.6373050212860107,
      "norm_score": 0.17473573982715607,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "temporal arteritis",
      "disease_id": "drkg:Disease::MESH:D013700",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.6260361671447754,
      "norm_score": 0.1735331118106842,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": true,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "autoimmune hemolytic anemia",
      "disease_id": "drkg:Disease::MESH:D000744",
      "disease_category": "autoimmune",
      "disease_tier": 1,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 13,
      "knn_score": 1.5821735858917236,
      "norm_score": 0.1729821115732193,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "autoimmune hemolytic anemia",
      "disease_id": "drkg:Disease::MESH:D000744",
      "disease_category": "autoimmune",
      "disease_tier": 1,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.5814018249511719,
      "norm_score": 0.17289774119853973,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "eczema",
      "disease_id": "drkg:Disease::MESH:D004485",
      "disease_category": "dermatological",
      "disease_tier": 1,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 14,
      "knn_score": 1.4111099243164062,
      "norm_score": 0.17081357538700104,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "lichen planus",
      "disease_id": "drkg:Disease::MESH:D008010",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 15,
      "knn_score": 1.5201475620269775,
      "norm_score": 0.14598582684993744,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "pemphigus foliaceus",
      "disease_id": "drkg:Disease::MESH:D010392",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 16,
      "knn_score": 1.4755043983459473,
      "norm_score": 0.14453543722629547,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "graft versus host disease gvhd",
      "disease_id": "drkg:Disease::MESH:D006086",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 19,
      "knn_score": 0.7523426413536072,
      "norm_score": 0.11437207460403442,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "pyoderma gangrenosum",
      "disease_id": "drkg:Disease::MESH:D017511",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 0.8212196826934814,
      "norm_score": 0.10325784981250763,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "vasculitis",
      "disease_id": "drkg:Disease::MESH:D014657",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Rituximab",
      "drug_id": "drkg:Compound::DB00073",
      "drug_type": "biologic",
      "rank": 17,
      "knn_score": 0.7659246325492859,
      "norm_score": 0.0979398712515831,
      "confidence_tier": "MEDIUM",
      "train_frequency": 10,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "lichen simplex chronicus neurodermatitis",
      "disease_id": "drkg:Disease::MESH:D009450",
      "disease_category": "dermatological",
      "disease_tier": 1,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 18,
      "knn_score": 0.7841470241546631,
      "norm_score": 0.09771648794412613,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    },
    {
      "disease_name": "pure red cell aplasia",
      "disease_id": "drkg:Disease::MESH:D012010",
      "disease_category": "other",
      "disease_tier": 2,
      "drug_name": "Adalimumab",
      "drug_id": "drkg:Compound::DB00051",
      "drug_type": "biologic",
      "rank": 20,
      "knn_score": 0.7836290597915649,
      "norm_score": 0.08712304383516312,
      "confidence_tier": "MEDIUM",
      "train_frequency": 11,
      "mechanism_support": false,
      "has_targets": true,
      "category_rescue_applied": false,
      "is_fda_approved": false,
      "is_broad_spectrum": false,
      "filter_exclusion": null
    }
  ]
}